Search
for

    Research 10 of 1000+

    1. 544 Alopecia areata lesions show significant changes in immune and keratin biomarkers that correlate with clinical improvement with oral Janus kinase inhibitors PF-06651600 (JAK3) and PF-06700841 (TYK2/JAK1) Journal of Investigative Dermatology · 2019 · 5 citations
    2. JAK inhibition in the treatment of alopecia areata – a promising new dawn? Expert review of clinical pharmacology · 2019 · 29 citations
    3. 695 Selectively targeting JAK1 or JAK3 pathway is sufficient to reverse alopecia areata 2019
    4. Evolution of Ritlecitinib Population Pharmacokinetic Models During Clinical Drug Development Clinical Pharmacokinetics · 2023 · 6 citations
    5. Ritlecitinib: First Approval Drugs · 2023 · 84 citations
    6. The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm Advances in Therapy · 2017 · 77 citations
    7. Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study Journal of The American Academy of Dermatology · 2021 · 66 citations
    8. Systemic treatments for alopecia areata: A systematic review Australasian journal of dermatology · 2018 · 41 citations
    9. New drugs under investigation for the treatment of alopecias Expert Opinion on Investigational Drugs · 2019 · 26 citations
    10. Validation of the Alopecia Areata Patient Priority Outcomes (AAPPO) Questionnaire in Adults and Adolescents with Alopecia Areata Dermatology and Therapy · 2021 · 22 citations
    All research results →

    Community 1 of 2

    1. Whats the goal pf Nizoral and Ketoconzole shampoos? Reddit · 30 Jan 2025
    All community results →

    Learn

    — no results

    Try a deeper search in learn →